Wellell Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Wellell ha aumentado sus beneficios a una tasa media anual de 11.4%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 11.4% anual. Los ingresos han ido creciendo a una tasa media de 7.2% al año. La rentabilidad financiera de Wellell es de 6.5%, y sus márgenes netos son de 5.7%.

Información clave

11.4%

Tasa de crecimiento de los beneficios

9.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	11.5%
Tasa de crecimiento de los ingresos	7.2%
Rentabilidad financiera	6.5%
Margen neto	5.7%
Próxima actualización de resultados	07 May 2024

Actualizaciones de resultados anteriores recientes

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Mar 23

Recent updates

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Mar 23

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Mar 29

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Mar 01

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Feb 11

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Jan 27

Is Apex Medical (TPE:4106) Using Too Much Debt?

Jan 12

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Dec 28

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Nov 27

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Wellell. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

TWSE:4106 Ingresos, gastos y beneficios (TWD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Dec 23	2,647	152	778	166
30 Sep 23	2,665	145	775	158
30 Jun 23	2,792	181	774	159
31 Mar 23	2,768	181	759	159
31 Dec 22	2,664	161	728	154
30 Sep 22	2,585	150	727	156
30 Jun 22	2,492	121	721	154
31 Mar 22	2,389	104	735	153
31 Dec 21	2,374	102	732	151
30 Sep 21	2,310	109	705	146
30 Jun 21	2,236	106	681	163
31 Mar 21	2,168	126	619	167
31 Dec 20	2,004	105	581	168
30 Sep 20	1,967	110	549	164
30 Jun 20	1,924	95	539	147
31 Mar 20	1,938	58	566	140
31 Dec 19	2,036	88	587	138
30 Sep 19	2,088	104	610	133
30 Jun 19	2,100	118	612	132
31 Mar 19	2,122	123	614	134
31 Dec 18	2,106	108	608	132
30 Sep 18	2,049	93	601	146
30 Jun 18	2,122	90	612	148
31 Mar 18	2,119	115	612	142
31 Dec 17	2,089	118	614	139
30 Sep 17	2,103	114	609	127
30 Jun 17	1,967	117	594	115
31 Mar 17	1,951	102	610	108
31 Dec 16	1,990	123	616	103
30 Sep 16	1,994	153	619	100
30 Jun 16	1,983	143	627	99
31 Mar 16	2,008	158	605	96
31 Dec 15	2,016	169	597	95
30 Sep 15	2,029	144	653	90
30 Jun 15	2,165	175	682	89
31 Mar 15	2,199	179	696	93
31 Dec 14	2,263	178	733	89
30 Sep 14	2,242	199	678	91
30 Jun 14	2,181	164	655	87
31 Mar 14	2,107	149	645	79
31 Dec 13	2,017	133	589	80
30 Sep 13	2,015	120	555	76
30 Jun 13	1,941	148	519	77

Ingresos de calidad: 4106 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(5.7%) de 4106 son inferiores a los del año pasado (6.1%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de 4106 han crecido un 11.4% al año en los últimos 5 años.

Acelerando crecimiento: 4106 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: 4106 tuvo un crecimiento negativo de los beneficios (-5.7%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (-19.4%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de 4106 (6.5%) se considera baja.

Wellell Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Full year 2023 earnings released: EPS: NT$1.51 (vs NT$1.60 in FY 2022)

Second quarter 2023 earnings released: EPS: NT$0.50 (vs NT$0.51 in 2Q 2022)

Full year 2022 earnings released: EPS: NT$1.60 (vs NT$1.01 in FY 2021)

Third quarter 2022 earnings released: EPS: NT$0.59 (vs NT$0.31 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.34 in 2Q 2021)

Recent updates

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer

Full year 2023 earnings released: EPS: NT$1.51 (vs NT$1.60 in FY 2022)

Wellell Inc., Annual General Meeting, Jun 24, 2024

Wellell Inc. Appoints Lee Pi Kai as Chief Strategy Officer

Wellell Inc. Announces Resignation of Tan, Jian-Qiang as Chief Operating Officer

Second quarter 2023 earnings released: EPS: NT$0.50 (vs NT$0.51 in 2Q 2022)

Upcoming dividend of NT$0.85 per share at 2.7% yield

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 16%

Wellell Inc. Appoints Shin-Ho,Chen as Corporate Governance Officer

Full year 2022 earnings released: EPS: NT$1.60 (vs NT$1.01 in FY 2021)

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$0.59 (vs NT$0.31 in 3Q 2021)

Insufficient new directors

Wellell Inc. Announces Change Member of Remuneration Committee

Second quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.34 in 2Q 2021)

Insufficient new directors

Apex Medical Corp. Approves Cash Dividend for the Year 2021

Apex Medical Corp. Announces Change of Alan Chang as Research and Development Officer, Effective May 31, 2022

Apex (Kunshan)Medical Corp. to Announce Production Can Be Resume Gradually

Apex Medical Corp. Announces On Behalf of the Subsidiaries Apex (Kunshan) Medical Corp. and Wellell (Kunshan) Co., Ltd. Extend Temporary Suspension of Production

Wellell (Kunshan) Co., Ltd. Announces the Temporary Suspension of Production

Full year 2021 earnings released: EPS: NT$1.01 (vs NT$1.04 in FY 2020)

Wellell Inc., Annual General Meeting, Jun 20, 2022

Third quarter 2021 earnings released: EPS NT$0.31 (vs NT$0.28 in 3Q 2020)

High number of new directors

High number of new directors

High number of new directors

Upcoming dividend of NT$0.55 per share

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.55 in 2Q 2020)

High number of new directors

High number of new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$0.29 (vs NT$0.074 in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$1.04 (vs NT$0.87 in FY 2019)

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Apex Medical Corp. Announces Executive Changes, Effective March 01, 2021

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Apex Medical Corp. Appoints Alan Chang as Director of R&D

New 90-day low: NT$25.65

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Is Apex Medical (TPE:4106) Using Too Much Debt?

New 90-day low: NT$28.00

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

New 90-day low: NT$28.90

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Third quarter 2020 earnings released: EPS NT$0.28

New 90-day low: NT$31.05

First half earnings released

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Desglose de ingresos y gastos
Beta